Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Statera Biopharma, Inc. (CBLI)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsSep-30-22Sep-30-21Jun-30-21Dec-31-20Sep-30-20Jun-30-20Mar-31-20Dec-31-19
   10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K
Net income     -2.4-2.4-2.1-2.4-2.6
Depreciation and amortization   [+]   0.00.00.00.00.0
Stock-based compensation      0.0   
Change in working capital     0.11.00.70.80.8
Other operating activities     -0.1-0.6-0.6-0.7-0.8
Cash from operations     -2.4-1.9-2.0-2.3-2.7
   
Capital expenditures   [+]   0.00.00.00.00.0
Sales of short-term investments     0.70.81.2 1.4
Other cash from investing     -0.7-0.8-1.2 -1.2
Cash from investing     0.10.00.00.20.2
   
Issuance of common stock, net     5.6 2.8  
Other cash from financing     -2.4  0.4 
Cash from financing     3.23.23.20.40.0
   
Free cash flow     -2.4-2.0-2.0-2.3-2.7
        Per share (diluted)     ($0.19)($0.16)($0.17)($0.20)($0.24)
   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy